Cancer

Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer
German Biotech Tubulis Raises Record €308M Series C for Ovarian Cancer Treatment
Previvor Edge Raises $3.3M to Shift Cancer Care From Reactive to Proactive
Placeholder
Plexāā Launches BLOOM 43 Wearable Device for Breast Surgery Preparation
BeSound Raises $6.8M to Expand Breast Cancer Screening for Dense Tissue and Younger Women
Mercy BioAnalytics Raises $59M Series B for Early Ovarian Cancer Detection Technology
Antiva Biosciences Reports Positive Phase 1b/2 Results for HPV Treatment
Teal Health Launches At-Home Cervical Cancer Screening in California
AbbVie Receives UK MHRA Approval for Ovarian Cancer Treatment ELAHERE
Imagion Raises $3.5M to Advance Breast Cancer Imaging Technology
Tempus Expands AI Care Platform into Breast Cancer Diagnostics
SimBioSys Receives Third FDA Clearance for AI-Powered Breast Cancer Surgery Platform
RadNet’s DeepHealth Completes Acquisition of AI Breast Health Company iCAD
Cooler Heads Raises $11M Series A for Chemotherapy Hair Loss Prevention Device
Medtech Startup The Blue Box Closes €3M Seed Round to Transform Breast Cancer Screening
Placeholder
London-based Plexāā Raises $4.5M to Launch Breast Surgery Device in the United States
Susan G. Komen Awards $10.8 Million in Breast Cancer Research Grants
Hera Biotech Acquires Point-of-Care Cervical Cancer Diagnostic HeraFem
Medical Device Company Dilon Raises $9M to Advance Breast Cancer Surgery Technology
How Faeth Therapeutics Brings Precision Nutrition to Women’s Cancers
Clairity Receives First FDA De Novo Authorization for AI-Based Breast Cancer Risk Prediction Platform
PHASE Scientific Secures $34M to Advance Urine-Based Women’s Health Diagnostics
Merck’s Immunotherapy Shows Survival Benefit in Platinum-Resistant Ovarian Cancer Trial
SpotitEarly Raises $20.3M to Launch AI and Dog-Powered Breast Cancer Detection Technology in the U.S.